SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models
Cells · 07.12.2024 · 13 (23) · 2023
DOI: 10.3390/cells13232023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 07.12.2024. Verfasst von Emily Jessop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Durham University, Durham DH1 3LE, UK. Hauptthemen laut MEDLINE: Sirtuin 2, Triple Negative Breast Neoplasms, Cytoskeleton, Cell Movement. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the Rosetrees Trust (M933) and Medical Research Council (MRC) Impact Acceleration Account (IAA) grants., Rosetrees Trust, Medical Research Council (MRC) Impact Acceleration Account (IAA).
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype characterised by the absence of targetable hormone receptors and increased metastatic rates. As nuclear softening strongly contributes to TNBC’s enhanced metastatic capacity, increasing the nuclear stiffness of TNBC cells may present a promising therapeutic avenue. Previous evidence has demonstrated the ability of Sirtuin 2 (SIRT2) inhibition to induce cytoskeletal reorganisation, a key factor in regulating nuclear mechanics. Thus, our study aimed to investigate the effect of SIRT2 inhibition on the nuclear mechanics and migratory behaviour of TNBC cells. To achieve this, SIRT2 was pharmacologically inhibited in MDA-MB-231 cells using AGK2, a SIRT2-specific inhibitor. Although SIRT2 inhibition had no effect on LINC complex composition, the AGK2-treated MDA-MB-231 cells displayed more prominent perinuclear organisations of acetylated α-tubulin, vimentin, and F-actin. Additionally, the nuclei of the AGK2-treated MDA-MB-231 cells exhibited greater resistance to collapse under osmotic shock. Scratch-wound assays also revealed that SIRT2 inhibition led to polarity defects in the MDA-MB-231 cells, while in vitro space-restrictive invasion assays highlighted their reduced migratory capacity upon AGK2 treatment. Taken together, our findings suggest that SIRT2 inhibition promotes a perinuclear cytoskeletal organisation in MDA-MB-231 cells, which enhances their nuclear rigidity and impedes their invasion through confined spaces in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, Durham University, Durham DH1 3LE, UK.
- School of Computing, Newcastle University, Newcastle upon Tyne NE4 5TG, UK.
ORCID-Profile: Emily Jessop
Förderung
- This research was funded by the Rosetrees Trust (M933) and Medical Research Council (MRC) Impact Acceleration Account (IAA) grants.
- Rosetrees Trust
- Medical Research Council (MRC) Impact Acceleration Account (IAA)
Zitieren
APA
Jessop, E., Young, N., Garcia-Del-Valle, B., Crusher, J. T., Obara, B., & Karakesisoglou, I. (2024). SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models. Cells, 13(23), 2023. https://doi.org/10.3390/cells13232023
Vancouver
Jessop E, Young N, Garcia-Del-Valle B, Crusher JT, Obara B, Karakesisoglou I. SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models. Cells. 2024;13(23):2023. doi:10.3390/cells13232023
BibTeX
@article{Jessop2024,
author = {Jessop, Emily and Young, Natalie and Garcia-Del-Valle, Beatriz and Crusher, Jack T and Obara, Boguslaw and Karakesisoglou, Iakowos},
title = {SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models},
journal = {Cells},
year = {2024},
volume = {13},
number = {23},
pages = {2023},
doi = {10.3390/cells13232023}
}
EUVIMED